Intranasal Oxytocin for Methamphetamine Withdrawal in Women
NCT05760807
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Methamphetamine Use Disorder
Interventions
DRUG:
Oxytocin nasal spray
Sponsor
Turning Point
Collaborators
[object Object]
[object Object]
[object Object]